Sherine E Gabriel

Author PubWeight™ 277.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 56.72
2 Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 41.47
3 Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 26.95
4 Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005 5.31
5 Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002 4.69
6 Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005 4.63
7 Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002 4.23
8 Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010 3.84
9 Predictors of infection in rheumatoid arthritis. Arthritis Rheum 2002 3.47
10 Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc 2002 3.09
11 Epidemiology of gout: is the incidence rising? J Rheumatol 2002 2.80
12 The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005 2.74
13 Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003 2.64
14 Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002 2.39
15 Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004 2.32
16 Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am 2004 2.28
17 The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007 2.25
18 Asthma and proinflammatory conditions: a population-based retrospective matched cohort study. Mayo Clin Proc 2012 2.17
19 High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum 2008 2.14
20 Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. J Rheumatol 2009 2.10
21 Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009 2.06
22 Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol 2008 2.02
23 Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002 2.01
24 Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 2011 2.01
25 The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 2008 1.94
26 The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 2011 1.91
27 Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol 2002 1.91
28 Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011 1.90
29 Autoantibodies and the risk of cardiovascular events. J Rheumatol 2009 1.89
30 Heart disease in psoriasis. J Am Acad Dermatol 2007 1.87
31 Therapeutic strategies in rheumatoid arthritis over a 40-year period. J Rheumatol 2004 1.85
32 The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol 2011 1.82
33 Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum 2007 1.76
34 Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol 2012 1.69
35 Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007 1.67
36 Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum 2004 1.67
37 Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 2010 1.67
38 Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 2010 1.55
39 Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 2006 1.51
40 Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J Rheumatol 2009 1.51
41 How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 2005 1.49
42 Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol 2012 1.46
43 Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007 1.45
44 Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis 2009 1.40
45 Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol 2009 1.38
46 Osteoporosis intervention following distal forearm fractures: a missed opportunity? Arch Intern Med 2002 1.36
47 Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum 2012 1.34
48 Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2013 1.30
49 A population based assessment of the use of orthopedic surgery in patients with rheumatoid arthritis. J Rheumatol 2002 1.30
50 Orthopedic surgery among patients with rheumatoid arthritis 1980-2007: a population-based study focused on surgery rates, sex, and mortality. J Rheumatol 2012 1.29
51 Higher body mass index is not associated with worse pain outcomes after primary or revision total knee arthroplasty. J Arthroplasty 2010 1.28
52 The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study. J Rheumatol 2004 1.27
53 Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 2009 1.27
54 The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases. Rheumatology (Oxford) 2010 1.24
55 Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Ann Rheum Dis 2011 1.23
56 Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis 2012 1.23
57 Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. Arthritis Rheum 2009 1.21
58 Preventive medical services among patients with rheumatoid arthritis. J Rheumatol 2003 1.19
59 Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheumatol 2005 1.18
60 A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture. Osteoporos Int 2004 1.16
61 Rheumatoid arthritis and cardiovascular disease. Am Heart J 2013 1.14
62 Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study. J Rheumatol 2011 1.12
63 C-reactive protein and heart failure after myocardial infarction in the community. Am J Med 2007 1.11
64 Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease. Arthritis Rheum 2005 1.06
65 Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol 2002 1.05
66 Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol 2010 1.04
67 Determinants of patient satisfaction in chronic illness. Arthritis Rheum 2002 1.02
68 Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis 2010 1.01
69 Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep 2010 1.00
70 Direct medical costs of polymyalgia rheumatica. Arthritis Rheum 2005 0.99
71 Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells. J Immunol 2010 0.98
72 Do rheumatoid arthritis patients have a higher risk for sleep apnea? J Rheumatol 2009 0.96
73 Economic evaluation of programs or interventions in the management of rheumatoid arthritis: defining a consensus-based reference case. J Rheumatol 2003 0.96
74 Primer: Demystifying risk--understanding and communicating medical risks. Nat Clin Pract Rheumatol 2007 0.95
75 Potential misclassification of patients with psoriasis in electronic databases. J Am Acad Dermatol 2008 0.95
76 Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Ann Rheum Dis 2011 0.95
77 B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations. Cardiovasc Pathol 2004 0.95
78 The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis. Value Health 2003 0.94
79 Malignancy risk in patients with giant cell arteritis: a population-based cohort study. Arthritis Care Res (Hoboken) 2010 0.94
80 Epidemiology of large-vessel vasculidities. Best Pract Res Clin Rheumatol 2010 0.92
81 Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study. Arthritis Care Res (Hoboken) 2013 0.91
82 Predictors of Dissection in Aortic Aneurysms From Giant Cell Arteritis. J Clin Rheumatol 2016 0.91
83 Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. J Rheumatol 2013 0.91
84 Autoantibodies: innocent bystander or key player in immunosenescence and atherosclerosis? J Rheumatol 2007 0.91
85 Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis? Arthritis Rheum 2010 0.89
86 Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort study. Arthritis Care Res (Hoboken) 2013 0.89
87 A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis. Arthritis Rheum 2011 0.88
88 Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect? J Rheumatol 2005 0.88
89 Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study. Arthritis Res Ther 2009 0.88
90 Osteopenia in adults with a history of juvenile rheumatoid arthritis. A population based study. J Rheumatol 2002 0.88
91 Reaching those most in need: a scoping review of interventions to improve health care quality for disadvantaged populations with osteoarthritis. Arthritis Care Res (Hoboken) 2011 0.88
92 Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis. J Rheumatol 2005 0.86
93 Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study. Rheumatology (Oxford) 2010 0.85
94 Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study. J Rheumatol 2013 0.84
95 Training the next generation of translational science teams. Clin Transl Sci 2008 0.84
96 Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study. J Rheumatol 2013 0.84
97 Frequency of radiologic procedures in patients with rheumatoid arthritis. J Clin Rheumatol 2015 0.84
98 Looking beyond translation--integrating clinical research with medical practice. N Engl J Med 2012 0.83
99 Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. Arthritis Rheum 2013 0.83
100 Cancer preceding giant cell arteritis: a case-control study. Arthritis Rheum 2010 0.82
101 Cardiovascular disease in rheumatoid arthritis: a step forward. Curr Opin Rheumatol 2010 0.81
102 Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken) 2011 0.81
103 A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis. Arthritis Res Ther 2012 0.80
104 Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis? Arthritis Rheum 2008 0.79
105 The need for microsimulation to evaluate osteoporosis interventions. Osteoporos Int 2005 0.79
106 Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study. Arthritis Care Res (Hoboken) 2013 0.79
107 Moving forward with quality: pay for reporting meets rheumatology. Arthritis Rheum 2007 0.79
108 Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity. Arthritis Res Ther 2013 0.78
109 Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis. Arthritis Rheum 2013 0.78
110 Rheumatoid arthritis and the heart. Curr Heart Fail Rep 2006 0.78
111 A call for evidence-based quality measures: a goal worthy of pursuit. Nat Clin Pract Rheumatol 2007 0.78
112 Ischemic heart disease and rheumatoid arthritis: comment on the article by Holmqvist et al. Arthritis Rheum 2010 0.77
113 Time trends in glucocorticoid use in rheumatoid arthritis: results from a population-based inception cohort, 1980-1994 versus 1995-2007. Arthritis Care Res (Hoboken) 2014 0.77
114 Lack of association of high body mass index with risk for developing polymyalgia rheumatica. Int J Rheum Dis 2010 0.77
115 Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis. Clin Immunol 2011 0.77
116 Addressing musculoskeletal health inequity in Africa. Arthritis Care Res (Hoboken) 2010 0.77
117 Reading and interpreting economic evaluations in rheumatoid arthritis: an assessment of selected instruments for critical appraisal. J Rheumatol 2003 0.76
118 Occurrence and effect of lower extremity ulcer in rheumatoid arthritis -- a population-based Study. J Rheumatol 2014 0.76
119 Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis. PLoS One 2017 0.75
120 The USPSTF recommendation statement on coronary heart disease risk assessment. Ann Intern Med 2010 0.75
121 Rheumatology gone global. Ann Rheum Dis 2008 0.75
122 Association of TNFSF8 polymorphisms with peripheral neutrophil count. Mayo Clin Proc 2011 0.75
123 Short-term outcomes of acute knee injuries: does the provider make a difference? Arthritis Rheum 2002 0.75
124 Rheumatology gone global. Arthritis Rheum 2008 0.75